Yingdi Han
Tianjin, 300100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Dioscin suppresses colitis-associated colorectal tumorigenesis by inhibiting PPARγ-mediated fatty acid oxidation in TAMs.
Journal: International immunopharmacology
Published: January 18, 2026
Baihua Dangen Tang inhibits the peritoneal metastasis of colon cancer by modulating the bacterial metabolite gentisic acid to suppress MDSCs.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 21, 2025
Neogambogic acid promotes M-MDSC differentiation into M1 macrophages to inhibit peritoneal metastasis of colorectal cancer.
Journal: International immunopharmacology
Published: September 16, 2025
The KDM6B/SLC10A2 Axis Suppresses MDSCs Recruitment via ERK/AP-1 Signaling in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 29, 2025
CircNOX4 promotes proliferation and resistance by regulating the hsa-miR-6884-5p/YWHAG Axis and ERK signaling pathway in cholangiocarcinoma.
Journal: Functional & integrative genomics
Published: April 18, 2025
FATS alleviates ulcerative colitis by inhibiting M1 macrophage polarization and aerobic glycolysis through promoting the ubiquitination-mediated degradation of HIF-1α.
Journal: Biochemical pharmacology
Published: February 07, 2025
Hydroxygenkwanin suppresses peritoneal metastasis in colorectal cancer by modulating tumor-associated macrophages polarization.
Journal: Chemico-biological interactions
Published: March 14, 2024
Neogambogic acid enhances anti-PD-1 immunotherapy efficacy by attenuating suppressive function of MDSCs in pancreatic cancer.
Journal: International immunopharmacology
Published: March 04, 2024
Incidence and risk factors for second malignancies among patients with myeloproliferative neoplasms.
Incidence and risk factors for second malignancies among patients with myeloproliferative neoplasms.
Journal: Cancer medicine
Published: September 21, 2022
Thrombosis in patients with post-polycythemia vera myelofibrosis: incidence and risk factors.
Journal: Thrombosis research
Published: August 08, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026